bezlotoxumab
serospecific
immunopharmacological
sintilimab
zenocutuzumab
immunoepidemiological
retifanlimab
sasanlimab
vanucizumab
immunoreactant
immunostate
ziltivekimab
solitomab
dinutuximab
toripalimab
intrabody
pozelimab
antiplasma
caplacizumab
immunosphere
immunostimulator
immunoexcitotoxic
tenatumomab
radioimmunoelectrophoresis
idiospecific
antimonoclonal
-lim-
drozitumab
-imus
immunotactoid
anti-
immunoprotector
immunopanning
oleclumab
immunoprobe
immunoliposome
glembatumumab
biciromab
abzyme
sulesomab
immunoinflammatory
polyclonal
monospecific
immunotag
zolimomab
panitumumab
telimomab
tisotumab
antisubstance
antiapoptosis